Opyl Ltd Cash Flow Conversion Efficiency
Opyl Ltd cash flow conversion efficiency. Based on the latest financial reports, Opyl Ltd (OPL) has a cash flow conversion efficiency ratio of 1.994x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-619.98K ≈ $-438.67K USD) by net assets (AU$-310.99K ≈ $-220.05K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Opyl Ltd (1996–2024)
Cash flow conversion efficiency of Opyl Ltd from 1996 to 2024. This chart illustrates how Opyl Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Opyl Ltd for real-time trading data and today's change.
Opyl Ltd Cash Flow Conversion Ratio Explained
Opyl Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Opyl Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Opyl Ltd ranked by their cash flow conversion efficiency. Also see Opyl Ltd (OPL) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Destiny Media Technologies Inc
V:DSY
|
0.158x |
|
D.T.C. Industries Public Company Limited
BK:DTCI
|
-0.015x |
|
Whitebark Energy Ltd
AU:WBE
|
0.308x |
|
AquaBounty Technologies Inc
NASDAQ:AQB
|
0.480x |
|
THOR MNG CUFS/1LS- 00001
F:T5MB
|
N/A |
|
Sinergi Inti Plastindo
JK:ESIP
|
0.003x |
|
TESGAS S.A.
WAR:TSG
|
-0.092x |
|
CASA DE BUCOVINA-CLUB DE MUNTE
RO:BCM
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Opyl Ltd (1996–2024)
The table below shows the annual cash flow conversion efficiency of Opyl Ltd from 1996 to 2024. Review Opyl Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | AU$-90.16K ≈ $-63.79K |
AU$-2.06 Million ≈ $-1.46 Million |
22.811x | +574.80% |
| 2023-06-30 | AU$-403.59K ≈ $-285.56K |
AU$-1.36 Million ≈ $-965.34K |
3.380x | +159.40% |
| 2022-06-30 | AU$267.01K ≈ $188.93K |
AU$-1.52 Million ≈ $-1.08 Million |
-5.691x | -1277.78% |
| 2021-06-30 | AU$2.19 Million ≈ $1.55 Million |
AU$-903.65K ≈ $-639.39K |
-0.413x | +71.13% |
| 2020-06-30 | AU$719.18K ≈ $508.86K |
AU$-1.03 Million ≈ $-728.08K |
-1.431x | -127.41% |
| 2019-06-30 | AU$-402.81K ≈ $-285.01K |
AU$-2.10 Million ≈ $-1.49 Million |
5.221x | +354.11% |
| 2018-06-30 | AU$1.39 Million ≈ $986.43K |
AU$-2.86 Million ≈ $-2.03 Million |
-2.054x | +83.53% |
| 2017-06-30 | AU$230.83K ≈ $163.32K |
AU$-2.88 Million ≈ $-2.04 Million |
-12.471x | -787.81% |
| 2016-06-30 | AU$2.22 Million ≈ $1.57 Million |
AU$-3.12 Million ≈ $-2.20 Million |
-1.405x | -377.56% |
| 2015-06-30 | AU$1.33 Million ≈ $937.83K |
AU$-389.85K ≈ $-275.85K |
-0.294x | -2234.34% |
| 2014-06-30 | AU$5.77 Million ≈ $4.09 Million |
AU$-72.76K ≈ $-51.48K |
-0.013x | +58.48% |
| 2013-06-30 | AU$8.31 Million ≈ $5.88 Million |
AU$-252.29K ≈ $-178.51K |
-0.030x | -110.59% |
| 2012-06-30 | AU$10.12 Million ≈ $7.16 Million |
AU$-145.87K ≈ $-103.21K |
-0.014x | +40.22% |
| 2011-06-30 | AU$14.17 Million ≈ $10.02 Million |
AU$-341.50K ≈ $-241.63K |
-0.024x | +96.37% |
| 2010-06-30 | AU$1.69 Million ≈ $1.19 Million |
AU$-1.12 Million ≈ $-793.50K |
-0.664x | -182.04% |
| 2009-06-30 | AU$-4.04 Million ≈ $-2.86 Million |
AU$-3.27 Million ≈ $-2.31 Million |
0.810x | +4568.99% |
| 2008-06-30 | AU$69.38 Million ≈ $49.09 Million |
AU$-1.26 Million ≈ $-889.41K |
-0.018x | +57.21% |
| 2007-06-30 | AU$59.61 Million ≈ $42.18 Million |
AU$-2.52 Million ≈ $-1.79 Million |
-0.042x | -41.86% |
| 2006-06-30 | AU$52.13 Million ≈ $36.89 Million |
AU$-1.56 Million ≈ $-1.10 Million |
-0.030x | +70.01% |
| 2005-06-30 | AU$13.41 Million ≈ $9.49 Million |
AU$-1.33 Million ≈ $-944.26K |
-0.100x | -367.82% |
| 2004-06-30 | AU$16.09 Million ≈ $11.38 Million |
AU$-342.24K ≈ $-242.16K |
-0.021x | +41.20% |
| 2003-06-30 | AU$10.47 Million ≈ $7.41 Million |
AU$-378.80K ≈ $-268.03K |
-0.036x | -20.83% |
| 2002-06-30 | AU$9.85 Million ≈ $6.97 Million |
AU$-294.88K ≈ $-208.64K |
-0.030x | +44.96% |
| 2001-06-30 | AU$8.89 Million ≈ $6.29 Million |
AU$-483.84K ≈ $-342.34K |
-0.054x | +36.89% |
| 2000-06-30 | AU$9.41 Million ≈ $6.66 Million |
AU$-811.63K ≈ $-574.28K |
-0.086x | -99.74% |
| 1999-06-30 | AU$6.41 Million ≈ $4.53 Million |
AU$-276.48K ≈ $-195.63K |
-0.043x | +7.67% |
| 1998-06-30 | AU$6.42 Million ≈ $4.54 Million |
AU$-299.97K ≈ $-212.25K |
-0.047x | +41.37% |
| 1997-06-30 | AU$6.21 Million ≈ $4.39 Million |
AU$-495.03K ≈ $-350.27K |
-0.080x | +53.83% |
| 1996-06-30 | AU$6.15 Million ≈ $4.35 Million |
AU$-1.06 Million ≈ $-751.81K |
-0.173x | -- |
About Opyl Ltd
Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool strea… Read more